Biogen, Eisai Alzheimer’s candidate lecanemab meets primary endpoint in late-stage trial Posted on September 28, 2022 By Charlielikes Stock Market Tags:alzheimer’s,, biogen, candidate, eisai, endpoint, in, late-stage, lecanemab, market, meets, primary, stock, stock market, trial